Femara Anti-Estrogen Powder Letrozole

Letrozole (Steroids) Femara Anti-Estrogen Powder Letrozole CAS NO.: 112809-51-5 Molecular Formula: C17H11N5 Molecular Weight: 285.31 White or light yellow crystal Usage: Used as API in Treatment of breast disease.

Effect: letrozole in postmenopausal patients with advanced breast cancer whose Estrogen receptor and / or progesterone receptor positive or receptor status unknown Femara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor.

Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer. 1. Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. 2.

For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. 3. It will also raise testosterone levels because of the lowered estrogen in the body. 4. Femara(generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women. 5.

Femara is the second in a new class of third-generation selective oral aromatase inhibitors. 6. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. cindy1114 (at)ycccreate (dot)com